Exact Sciences Corp (NAS:EXAS)
$ 49.84 -4.24 (-7.84%) Market Cap: 9.20 Bil Enterprise Value: 11.10 Bil PE Ratio: 0 PB Ratio: 2.93 GF Score: 80/100

Exact Sciences Corp at Bank of America Healthcare Conference Transcript

May 11, 2022 / 09:00PM GMT
Release Date Price: $48.2 (-6.26%)
Derik De Bruin
BofA Securities, Research Division - MD of Equity Research

Welcome to the 2022 Bank of America Healthcare Conference, coming to you live from Las Vegas.

I'm Derik De Bruin, the senior life sciences and diagnostics tools analyst. And it's our pleasure to welcome our next company, Exact Sciences.

And with us today is Kevin Conroy, Chairman and CEO; and Brian Baranick. And I didn't get your title since you're a sub for Jeff.

Brian Baranick

Senior Vice President of Strategy and Business Development.

Derik De Bruin;Kevin T. Conroy
BofA Securities, Research Division - MD of Equity Research;Exact Sciences Corporation -

All right, there we go. All good.

So sort of boring in your space, nothing really going on. So I don't know what we're going to spend 30 minutes talking about because it's just no controversy, nothing going on, just boring, boring, boring.

And with that, any opening marks, Kevin? Or you just want to sort of like jump into it?

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot